Outcomes Following Delta Xtend Reverse Shoulder System

Rothman Institute Orthopaedics

Status: Unknown

Conditions: Reverse Total Shoulder Arthroplasty

Treatments: Device: DePuy Delta Xtend Reverse TSA

Study type: Observational

Funder types: Other

Identifiers

NCT02014350

RI2013

Details and patient eligibility

About

To collect medium to long-term survivorship implant outcomes on the DePuy Delta Xtend Reverse Shoulder Stystem.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Patients whom were implanted with the DePuy Delta Xtend Reverse Total Shoulder System in the time frame indicated. Patients must be willing to sign the consent form and complete all follow-up visits.

Trial design

0 participants in 1 patient group

DePuy Delta Xtend RTSA

Treatment:

Device: DePuy Delta Xtend Reverse TSA